Targeting a Signaling Pathway Activated by Acidic Tumor Environment Restores Treatment Response to PARP Inhibitors in Ovarian Cancer
HOUSTON, July 30: Researchers at The University of Texas MD Anderson Cancer Center have discovered a promising strategy to overcome PARP…
